Select Page

MULPLETA (lusutrombopag tablets) for oral use. Initial U.S. Approval: 2018

MULPLETA (lusutrombopag tablets) for oral use. Initial U.S. Approval: 2018

MULPLETA is a Anti Cancer medicine. MULPLETA is used to treat low platelet count (thrombocytopenia) in adults with chronic liver disease.
INDICATIONS AND USAGE
MULPLETA is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
DOSAGE FORMS & STRENGTHS
Tablet: 3 mg
Manufactured By: Shionogi Inc.
Prescribing Information URL: Click Here

Procedure to buy MULPLETA (lusutrombopag tablets) for oral use?
To buy MULPLETA (lusutrombopag tablets) for oral use, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Lusutrombopag, sold under the brand name Mulpleta among others, is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts) such as thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures. It is being manufactured and marketed in Japan by Shionogi. It was approved by the U.S. Food and Drug Administration (FDA) in July 2018, and NICE in January 2020.It was approved for medical use in the European Union in February 2019.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

MULPLETA (lusutrombopag tablets) in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
MULPLETA (lusutrombopag tablets) in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
MULPLETA (lusutrombopag tablets) in North America – Mexico.
MULPLETA (lusutrombopag tablets) in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
MULPLETA (lusutrombopag tablets) in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
MULPLETA (lusutrombopag tablets) in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
MULPLETA (lusutrombopag tablets) in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
MULPLETA (lusutrombopag tablets) in Australia and New Zealand.

For Indian Patient

Ani-Cancer MULPLETA (lusutrombopag tablets) are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

MULPLETA (lusutrombopag tablets) can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “MULPLETA (lusutrombopag tablets) for oral use. Initial U.S. Approval: 2018”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.